Skip To Main Content
Campus
  • Tiede
  • Materiaalit
Campus
  • Tiede
  • Materiaalit

Artikkelit

Järjestä

Suodattimet

Nollaa
  • Terapia-alue

Need to identify risk of developing autoimmune type 1 diabetes? Test for autoantibodies!

Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.1 The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.2 Assays for detecting autoimmune T1D have shown high sensitivity and specificity.3,4

Lue lisää

Exploring the Unique Characteristics of Atopic Dermatitis (AD) and Prurigo Nodularis (PN)

Explore the distinct clinical manifestations of Atopic Dermatitis (AD) and Prurigo Nodularis (PN), their impact on patients' lives, and the common thread of type 2 inflammation. Understand how these chronic skin conditions differ and intersect in this comprehensive overview.

Lue lisää

Switching from other basal insulins to Toujeo (Insulin Glargine)

Lue lisää

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Lue lisää

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Lue lisää

When to Initiate Basal Insulin?

Practical Guidance based on the 2022 ADA/EASD Guidelines.

Lue lisää

Approach for patients with peripheral artery disease (PAD) + T2DM: focus on LDL-C control

Lue lisää

Cardiovascular diseases (CVDs) are the leading cause of death globally

Lue lisää

When to suspect TTP?

TTP is rare and presents similarly to other thrombotic microangiopathies (TMAs), making it difficult to diagnose.

Lue lisää

Signs and symptoms of aTTP

Know the signs and symptoms of acquired TTP (aTTP).

Lue lisää

What is TTP? A rare, life-threatening medical emergency

Early diagnosis and treatment of Thrombotic thrombocytopenic purpura (TTP) can help prevent the high risk of early deaths.

Lue lisää

Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Summary of Aschner P, et al. Diabetologia. 2020;63(4):711-721.

Lue lisää